REQUEST A DEMO
Total
USD $0.00
Search more companies

Madipost Co.,Ltd. (South Korea)

Main Activities: Chemical Manufacturing | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: Madipost Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Medipost Co., Ltd. is a stem cell biotechnology company based in Korea. The company focuses on developing products to address unmet medical needs. Medipost operates through four segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division collects and stores stem cells from newborns' umbilical cords. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics. Medipost's mission is to help patients with incurable diseases and address unmet medical needs through stem cells and regenerative medicine. Since its foundation in 2000, Medipost has been a leader in the global stem cell therapeutics field. They have developed the world's first regulatory-approved allogeneic human Umbilical Cord Blood-derived Mesenchymal Stem Cell (hUCB-MSC) product called CARTISTEM® for patients with knee Osteoarthritis (OA). Medipost has received over 33 public R&D grants for the commercialization of stem cell therapeutics. They are committed to overcoming the boundaries of currently incurable diseases and unmet medical needs through their research and development efforts in stem cell technology and commercialization.

Headquarters
21 Daewangpangyo-Ro 644Beon-Gil, Bundang-Gu
Seongnam; Gyeonggi; Postal Code: 463-400

Contact Details: Purchase the Madipost Co.,Ltd. report to view the information.

Website: http://www.medi-post.co.kr

Basic Information
Total Employees:
Purchase the Madipost Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Madipost Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Madipost Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Madipost Co.,Ltd. report to view the information.
Incorporation Date:
June 26, 2000
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
6.99%
Purchase this report to view the information.
0.21%
Subsidiaries
메디포스트메디투어㈜
100%
Medipost America Inc
99.86%
(주)셀리노
50%
Company Performance
Financial values in the chart are available after Madipost Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
28.71%
Total operating revenue
17.57%
Operating profit (EBIT)
-320.18%
EBITDA
-987.12%
Net Profit (Loss) for the Period
-13.17%
Total assets
75.49%
Total equity
67.4%
Operating Profit Margin (ROS)
-29.15%
Net Profit Margin
1.63%
Return on Equity (ROE)
1.27%
Debt to Equity Ratio
14.34%
Quick Ratio
-0.67%
Cash Ratio
0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?